Precigen – Talk Bio

FDA Grants Full Approval to Precigen’s Papzimeos for Rare Disease RRP

4 weeks ago talkbio0Tagged Approved, Episodic, gene therapy, Immunotherapy, Infrequent, orphan drug designation, Papzimeos, Precigen, Recurrent respiratory papillomatosis, RRP, United States Food and Drug Administration

Precigen; Papzimeos; FDA approval; recurrent respiratory papillomatosis (RRP); gene therapy; immunotherapy; rare disease; Orphan Drug designation

Precigen Receives FDA Approval for First Immunotherapy for HPV-Related Recurrent Respiratory Papillomatosis

4 weeks ago talkbio0Tagged Adenovirus Vector, Approved, Episodic, gene therapy, human papillomavirus, Identifier, Immunotherapy, Papzimeos, Precigen, Recurrent respiratory papillomatosis, RRP, United States Food and Drug Administration, zopapogene imadenovec-drba

Precigen; FDA approval; Papzimeos; zopapogene imadenovec-drba; HPV; recurrent respiratory papillomatosis (RRP); immunotherapy; gene therapy; adenoviral vector; Breakthrough Therapy designation

Precigen Restructures, Reduces CAR-T Efforts Amid Job Cuts

1 year ago talkbio0Tagged AdenoVerse, CAR-T, gene therapy, Precigen, restructuring

Precigen, CAR-T, restructuring, job cuts, UltraCAR-T, gene therapy, AdenoVerse, PRGN-2012

Biopharma Layoff Tracker 2024: Precigen, Sumitomo, BMS and More Cut Staff

1 year ago talkbio0Tagged Biopharma layoffs, Industry, Myers, pharmaceutical companies, Precigen, restructuring, squibb, Sumitomo

biopharma layoffs, Precigen, Sumitomo, Bristol Myers Squibb, biotech industry, job cuts, restructuring, pharmaceutical companies